2014
DOI: 10.1055/s-0034-1396500
|View full text |Cite
|
Sign up to set email alerts
|

Neue zielgerichtete konservative Therapie akuter und chronischer Chorioretinopathia centralis serosa (RCS) mit Spironolacton im Vergleich zu Observation und Azetazolamid

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles